v3.26.1
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
10 Months Ended
Aug. 13, 2026
Jun. 30, 2026
Jun. 05, 2026
Jun. 12, 2025
Mar. 31, 2026
Mar. 24, 2026
Jun. 10, 2025
Jun. 06, 2025
Common stock par value         $ 0.0001   $ 0.0001 $ 0.0001
Authorized capital              
Zoar Labs Limited [Member]                
Authorized capital       $ 50,000        
Number of shares issued       500,000,000        
Share price       $ 0.0001        
Contribution of ownership interests description       Following the formation of Zoar Labs Limited and execution of the Merger Agreement, on July 7, 2025, the DA Shareholder, as sole shareholder of Zoar HK Limited (then known as Dr Ashleys Limited), a Hong Kong registered company (the “HK Sub”), entered into a Sale and Purchase Agreement with Zoar Labs Limited, pursuant to which he contributed 100% of his shareholding in the capital of the HK Sub to Zoar Labs Limited, in exchange for the issuance of 99 ordinary shares of Zoar Labs Limited, par value $0.0001 per share, to the DA Shareholder. As a result of the contribution, the HK Sub became a wholly owned subsidiary of Zoar Labs Limited, and the DA Shareholder owned 100 ordinary shares of Zoar Labs Limited, par value $0.0001 per share.        
Merger Agreement [Member]                
Common stock par value             0.0001  
Merger Agreement [Member] | Zoar Labs Limited [Member]                
Common stock par value             $ 0.0001  
Repayment Agreement [Member]                
Accrued but unpaid principal, fees and charges outstanding           $ 8,000,000    
Number of shares issued     $ 1,334,000          
Stockholders equity description     Upon listing, the charged PubCo Shares are required to maintain a minimum aggregate market value of at least $8,000,000. If the aggregate market value of the charged PubCo Shares falls below $6,000,000, additional shares are required to be charged to restore the aggregate market value to at least $8,000,000.          
Common Stock [Member]                
Authorized capital         $ 0      
Number of shares issued         1      
Common Stock [Member] | June 2026 Amendment [Member]                
Share consideration   168,076,000            
Percentage of shares issued and outstanding   93.38%            
Common Stock [Member] | June 2026 Amendment [Member] | DSS Inc [Member]                
Share consideration   128,000            
Common Stock [Member] | June 2026 Amendment [Member] | Chief Executive Officer [Member]                
Share consideration   22,000            
Common Stock [Member] | August 2026 Amendment [Member] | Subsequent Event [Member]                
Share consideration 167,976,000              
Percentage of shares issued and outstanding 93.32%              
Common Stock [Member] | August 2026 Amendment [Member] | DSS Inc [Member] | Subsequent Event [Member]                
Share consideration 228,000